Trawicki Roman

Avg. Two Year Performance

No purchase track record
(30%) Avg. Sale Return
(14%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%(4%)(9%)(14%)(30%)
Sale Success Rate7 of 143 of 142 of 140 of 140 of 14
Drugs » Drug Manufacturers - Major

Executive Vice President:

Holdings: 8.22K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--